HEAD

Study gives more insight into head, neck cancer patients resistance to chemotherapy

The researchers searched through a chemical library, a tool frequently used in drug discovery, and discovered two compounds that may specifically target the two genes and render cancer cells resistant to the chemotherapy medication cisplatin approximately 30 times more susceptible to it.